Background Preliminary reports of studies involving simple coronary lesions indicate that a
sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary …

Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain. …

The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope
for antibacterial drug discoverers, who now had the tools to search entire genomes for new …

Background Percutaneous coronary intervention (PCI) involving drug-eluting stents is
increasingly used to treat complex coronary artery disease, although coronary-artery bypass …

The recommendations listed in this CPG are, whenever possible, evidence based. An extensive
evidence review was conducted through October 2012, and other selected references …

A simple and rapid method for preparing plasmids for restriction enzyme analysis has been
developed. Bacteria are boiled for 15–40 s and an insoluble clot of genomic DNA and debris …

Background—Coronary endothelial dysfunction is characterized by vasoconstrictive response
to the endothelium-dependent vasodilator acetylcholine. Although endothelial dysfunction …

Background— In patients undergoing percutaneous coronary intervention (PCI) in the modern
era, the incidence and prognostic implications of acute renal failure (ARF) are unknown. …

Background In patients with non-valvular atrial fibrillation, embolic stroke is thought to be
associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of …

… By Ken Arnold, James Gosling, David Holmes … Now, Ken Arnold, James Gosling, and
David Holmes have updated this classic to reflect the major enhancements in Java™ 2 …